| Detection and activity profiling of synthetic cannabinoids and their metabolites with a newly developed bioassay A Cannaert, J Storme, F Franz, V Auwärter, CP Stove Analytical chemistry 88 (23), 11476-11485, 2016 | 165 | 2016 |
| Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL … A Cannaert, E Sparkes, E Pike, JL Luo, A Fang, RC Kevin, R Ellison, ... ACS Chemical Neuroscience 11 (24), 4434-4446, 2020 | 91 | 2020 |
| Activity-based detection of consumption of synthetic cannabinoids in authentic urine samples using a stable cannabinoid reporter system A Cannaert, F Franz, V Auwärter, CP Stove Analytical chemistry 89 (17), 9527-9536, 2017 | 89 | 2017 |
| Report on a novel emerging class of highly potent benzimidazole NPS opioids: chemical and in vitro functional characterization of isotonitazene P Blanckaert, A Cannaert, K Van Uytfanghe, F Hulpia, E Deconinck, ... Drug Testing and Analysis 12 (4), 422-430, 2020 | 83 | 2020 |
| Application of an activity‐based receptor bioassay to investigate the in vitro activity of selected indole‐and indazole‐3‐carboxamide‐based synthetic cannabinoids at CB1 and … C Noble, A Cannaert, K Linnet, CP Stove Drug Testing and Analysis 11 (3), 501-511, 2019 | 81 | 2019 |
| Enantiospecific synthesis, chiral separation, and biological activity of four indazole-3-carboxamide-type synthetic cannabinoid receptor agonists and their detection in seized … LH Antonides, A Cannaert, C Norman, L Vives, A Harrison, A Costello, ... Frontiers in chemistry 7, 321, 2019 | 64 | 2019 |
| The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent‐4en and but‐3en analogues including MDMB‐4en‐PINACA AJ Krotulski, A Cannaert, C Stove, BK Logan Drug testing and analysis 13 (2), 427-438, 2021 | 57 | 2021 |
| In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances MM Vandeputte, A Cannaert, CP Stove Archives of toxicology 94 (11), 3819-3830, 2020 | 54 | 2020 |
| Activity-based concept to screen biological matrices for opiates and (synthetic) opioids A Cannaert, L Vasudevan, M Friscia, ALA Mohr, SMR Wille, CP Stove Clinical chemistry 64 (8), 1221-1229, 2018 | 53 | 2018 |
| Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐tert‐leucine E Wouters, L Mogler, A Cannaert, V Auwärter, C Stove Drug testing and analysis 11 (8), 1183-1191, 2019 | 47 | 2019 |
| Activity-based detection of cannabinoids in serum and plasma samples A Cannaert, J Storme, C Hess, V Auwärter, SMR Wille, CP Stove Clinical chemistry 64 (6), 918-926, 2018 | 45 | 2018 |
| Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform L Vasudevan, M Vandeputte, M Deventer, E Wouters, A Cannaert, ... Biochemical pharmacology 177, 113910, 2020 | 44 | 2020 |
| Molecular dissection of the human A3 adenosine receptor coupling with β-arrestin2 J Storme, A Cannaert, K Van Craenenbroeck, CP Stove Biochemical pharmacology 148, 298-307, 2018 | 42 | 2018 |
| First report on brorphine: the next opioid on the deadly new psychoactive substance horizon? N Verougstraete, MM Vandeputte, C Lyphout, A Cannaert, F Hulpia, ... Journal of Analytical Toxicology 44 (9), 937-946, 2020 | 41 | 2020 |
| Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using … KE Grafinger, MM Vandeputte, A Cannaert, A Ametovski, E Sparkes, ... Drug testing and analysis 13 (7), 1412-1429, 2021 | 39 | 2021 |
| Shape matters: The application of activity‐based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists … LH Antonides, A Cannaert, C Norman, N NicDáeid, OB Sutcliffe, CP Stove, ... Drug Testing and Analysis 13 (3), 628-643, 2021 | 36 | 2021 |
| Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine TM Gampfer, L Wagmann, YM Park, A Cannaert, J Herrmann, ... Archives of Toxicology 94, 2009-2025, 2020 | 34 | 2020 |
| Activity-based detection and bioanalytical confirmation of a fatal carfentanil intoxication A Cannaert, L Ambach, P Blanckaert, CP Stove Frontiers in Pharmacology 9, 486, 2018 | 31 | 2018 |
| Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F‐APP‐PICA and AMB‐FUBINACA as model compounds D Fabregat‐Safont, M Mardal, C Noble, A Cannaert, CP Stove, JV Sancho, ... Drug testing and analysis 11 (9), 1358-1368, 2019 | 30 | 2019 |
| In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor E Pottie, A Cannaert, CP Stove Archives of toxicology 94 (10), 3449-3460, 2020 | 29 | 2020 |
